| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |